Pursuant to the Government’s thrust towards Universal Health Care (UHC) and in light of the major changes in the pharmaceutical landscape, the Department of Health (DOH), through the Pharmaceutical Division (PD), crafted the Philippine Medicines Policy which would be implemented from the years 2022 to 2030 to mobilize all key players in the pharmaceutical sector to implement evidence-based policies, improve sustainability programs and leverage best practices throughout the pharmaceutical supply chain.
The Department of Health will conduct series of virtual trainings on Antimicrobial Stewardship this August and October 2022.
The Department of Health informs all DOH and CHD officials, Philhealth and DOH hospitals and health facilities on the Exemption from Import Duties, Taxes and Other Fees for the Procurement, continue reading : DOH clarifies exemptions of COVID-19 Vaccines not listed under the latest PNF.
The Department of Health will hold a consultative meeting via Webex platform on 08 June 2022, 2:00-4:00 PM to get the comments and feedback of medical centers, hospitals, sanitaria and specialty hospitals on the newly-developed COVID-19 medicines tracker.
The Department of Health-Pharmaceutical Division (DOH-PD) conducted a face-to-face Program Implementation Review (PIR) and updates on the different programs of the Pharmaceutical Division in Coron Palawan last April 26-28, 2022 after two years of restrictions from the COVID-19 pandemic.